The 6 analysts offering 12-month price forecasts for Harpoon Therapeutics Inc have a median target of 25.50, with a high estimate of 28.00 and a low estimate of 23.00. The median estimate represents a +74.42% increase from the last price of 14.62.
The current consensus among 6 polled investment analysts is to Buy stock in Harpoon Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.62
Reporting Date Mar 12
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.